BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

749 related articles for article (PubMed ID: 24388019)

  • 1. Preemptive genotyping for personalized medicine: design of the right drug, right dose, right time-using genomic data to individualize treatment protocol.
    Bielinski SJ; Olson JE; Pathak J; Weinshilboum RM; Wang L; Lyke KJ; Ryu E; Targonski PV; Van Norstrand MD; Hathcock MA; Takahashi PY; McCormick JB; Johnson KJ; Maschke KJ; Rohrer Vitek CR; Ellingson MS; Wieben ED; Farrugia G; Morrisette JA; Kruckeberg KJ; Bruflat JK; Peterson LM; Blommel JH; Skierka JM; Ferber MJ; Black JL; Baudhuin LM; Klee EW; Ross JL; Veldhuizen TL; Schultz CG; Caraballo PJ; Freimuth RR; Chute CG; Kullo IJ
    Mayo Clin Proc; 2014 Jan; 89(1):25-33. PubMed ID: 24388019
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preemptive Pharmacogenomic Testing for Precision Medicine: A Comprehensive Analysis of Five Actionable Pharmacogenomic Genes Using Next-Generation DNA Sequencing and a Customized CYP2D6 Genotyping Cascade.
    Ji Y; Skierka JM; Blommel JH; Moore BE; VanCuyk DL; Bruflat JK; Peterson LM; Veldhuizen TL; Fadra N; Peterson SE; Lagerstedt SA; Train LJ; Baudhuin LM; Klee EW; Ferber MJ; Bielinski SJ; Caraballo PJ; Weinshilboum RM; Black JL
    J Mol Diagn; 2016 May; 18(3):438-445. PubMed ID: 26947514
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of the Implementation of Pharmacogenomic Testing in a Pediatric Tertiary Care Setting.
    Cohn I; Manshaei R; Liston E; Okello JBA; Khan R; Curtis MR; Krupski AJ; Jobling RK; Kalbfleisch K; Paton TA; Reuter MS; Hayeems RZ; Verstegen RHJ; Goldman A; Kim RH; Ito S
    JAMA Netw Open; 2021 May; 4(5):e2110446. PubMed ID: 34037732
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Integrating pharmacogenomics into the electronic health record by implementing genomic indicators.
    Caraballo PJ; Sutton JA; Giri J; Wright JA; Nicholson WT; Kullo IJ; Parkulo MA; Bielinski SJ; Moyer AM
    J Am Med Inform Assoc; 2020 Jan; 27(1):154-158. PubMed ID: 31591640
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Electronic Medical Record-Integrated Pharmacogenomics and Related Clinical Decision Support Concepts.
    Caraballo PJ; Bielinski SJ; St Sauver JL; Weinshilboum RM
    Clin Pharmacol Ther; 2017 Aug; 102(2):254-264. PubMed ID: 28390138
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Feasibility of incorporating genomic knowledge into electronic medical records for pharmacogenomic clinical decision support.
    Overby CL; Tarczy-Hornoch P; Hoath JI; Kalet IJ; Veenstra DL
    BMC Bioinformatics; 2010 Oct; 11 Suppl 9(Suppl 9):S10. PubMed ID: 21044357
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacogenomics Clinical Annotation Tool (PharmCAT).
    Sangkuhl K; Whirl-Carrillo M; Whaley RM; Woon M; Lavertu A; Altman RB; Carter L; Verma A; Ritchie MD; Klein TE
    Clin Pharmacol Ther; 2020 Jan; 107(1):203-210. PubMed ID: 31306493
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Implementation of preemptive DNA sequence-based pharmacogenomics testing across a large academic medical center: The Mayo-Baylor RIGHT 10K Study.
    Wang L; Scherer SE; Bielinski SJ; Muzny DM; Jones LA; Black JL; Moyer AM; Giri J; Sharp RR; Matey ET; Wright JA; Oyen LJ; Nicholson WT; Wiepert M; Sullard T; Curry TB; Rohrer Vitek CR; McAllister TM; St Sauver JL; Caraballo PJ; Lazaridis KN; Venner E; Qin X; Hu J; Kovar CL; Korchina V; Walker K; Doddapaneni H; Wu TJ; Raj R; Denson S; Liu W; Chandanavelli G; Zhang L; Wang Q; Kalra D; Karow MB; Harris KJ; Sicotte H; Peterson SE; Barthel AE; Moore BE; Skierka JM; Kluge ML; Kotzer KE; Kloke K; Vander Pol JM; Marker H; Sutton JA; Kekic A; Ebenhoh A; Bierle DM; Schuh MJ; Grilli C; Erickson S; Umbreit A; Ward L; Crosby S; Nelson EA; Levey S; Elliott M; Peters SG; Pereira N; Frye M; Shamoun F; Goetz MP; Kullo IJ; Wermers R; Anderson JA; Formea CM; El Melik RM; Zeuli JD; Herges JR; Krieger CA; Hoel RW; Taraba JL; St Thomas SR; Absah I; Bernard ME; Fink SR; Gossard A; Grubbs PL; Jacobson TM; Takahashi P; Zehe SC; Buckles S; Bumgardner M; Gallagher C; Fee-Schroeder K; Nicholas NR; Powers ML; Ragab AK; Richardson DM; Stai A; Wilson J; Pacyna JE; Olson JE; Sutton EJ; Beck AT; Horrow C; Kalari KR; Larson NB; Liu H; Wang L; Lopes GS; Borah BJ; Freimuth RR; Zhu Y; Jacobson DJ; Hathcock MA; Armasu SM; McGree ME; Jiang R; Koep TH; Ross JL; Hilden MG; Bosse K; Ramey B; Searcy I; Boerwinkle E; Gibbs RA; Weinshilboum RM
    Genet Med; 2022 May; 24(5):1062-1072. PubMed ID: 35331649
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical pharmacogenomics testing in the era of next generation sequencing: challenges and opportunities for precision medicine.
    Ji Y; Si Y; McMillin GA; Lyon E
    Expert Rev Mol Diagn; 2018 May; 18(5):411-421. PubMed ID: 29634383
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PACE Forward-Making Pharmacogenomics Testing Available for Real-Life Clinical Utility.
    Lazaridis KN
    Clin Pharmacol Ther; 2019 Jan; 105(1):42-44. PubMed ID: 30520030
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Making pharmacogenomic-based prescribing alerts more effective: A scenario-based pilot study with physicians.
    Overby CL; Devine EB; Abernethy N; McCune JS; Tarczy-Hornoch P
    J Biomed Inform; 2015 Jun; 55():249-59. PubMed ID: 25957826
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Usability evaluation of pharmacogenomics clinical decision support aids and clinical knowledge resources in a computerized provider order entry system: a mixed methods approach.
    Devine EB; Lee CJ; Overby CL; Abernethy N; McCune J; Smith JW; Tarczy-Hornoch P
    Int J Med Inform; 2014 Jul; 83(7):473-83. PubMed ID: 24874987
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Simplifying the use of pharmacogenomics in clinical practice: Building the genomic prescribing system.
    Danahey K; Borden BA; Furner B; Yukman P; Hussain S; Saner D; Volchenboum SL; Ratain MJ; O'Donnell PH
    J Biomed Inform; 2017 Nov; 75():110-121. PubMed ID: 28963061
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacogenomics decision support in the U-PGx project: Results and advice from clinical implementation across seven European countries.
    Blagec K; Swen JJ; Koopmann R; Cheung KC; Crommentuijn-van Rhenen M; Holsappel I; Konta L; Ott S; Steinberger D; Xu H; Cecchin E; Dolžan V; Dávila-Fajardo CL; Patrinos GP; Sunder-Plassmann G; Turner RM; Pirmohamed M; Guchelaar HJ; Samwald M;
    PLoS One; 2022; 17(6):e0268534. PubMed ID: 35675343
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Integrating Pharmacogenetics in Clinical Care (I-PICC) Study: Protocol for a point-of-care randomized controlled trial of statin pharmacogenetics in primary care.
    Vassy JL; Brunette CA; Majahalme N; Advani S; MacMullen L; Hau C; Zimolzak AJ; Miller SJ
    Contemp Clin Trials; 2018 Dec; 75():40-50. PubMed ID: 30367991
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluating the frequency and the impact of pharmacogenetic alleles in an ancestrally diverse Biobank population.
    Verma SS; Keat K; Li B; Hoffecker G; Risman M; ; Sangkuhl K; Whirl-Carrillo M; Dudek S; Verma A; Klein TE; Ritchie MD; Tuteja S
    J Transl Med; 2022 Nov; 20(1):550. PubMed ID: 36443877
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Tutorial for Pharmacogenomics Implementation Through End-to-End Clinical Decision Support Based on Ten Years of Experience from PREDICT.
    Liu M; Vnencak-Jones CL; Roland BP; Gatto CL; Mathe JL; Just SL; Peterson JF; Van Driest SL; Weitkamp AO
    Clin Pharmacol Ther; 2021 Jan; 109(1):101-115. PubMed ID: 33048353
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Towards population-specific pharmacogenomics in the era of next-generation sequencing.
    Ji X; Ning B; Liu J; Roberts R; Lesko L; Tong W; Liu Z; Shi T
    Drug Discov Today; 2021 Aug; 26(8):1776-1783. PubMed ID: 33892143
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design and anticipated outcomes of the eMERGE-PGx project: a multicenter pilot for preemptive pharmacogenomics in electronic health record systems.
    Rasmussen-Torvik LJ; Stallings SC; Gordon AS; Almoguera B; Basford MA; Bielinski SJ; Brautbar A; Brilliant MH; Carrell DS; Connolly JJ; Crosslin DR; Doheny KF; Gallego CJ; Gottesman O; Kim DS; Leppig KA; Li R; Lin S; Manzi S; Mejia AR; Pacheco JA; Pan V; Pathak J; Perry CL; Peterson JF; Prows CA; Ralston J; Rasmussen LV; Ritchie MD; Sadhasivam S; Scott SA; Smith M; Vega A; Vinks AA; Volpi S; Wolf WA; Bottinger E; Chisholm RL; Chute CG; Haines JL; Harley JB; Keating B; Holm IA; Kullo IJ; Jarvik GP; Larson EB; Manolio T; McCarty CA; Nickerson DA; Scherer SE; Williams MS; Roden DM; Denny JC
    Clin Pharmacol Ther; 2014 Oct; 96(4):482-9. PubMed ID: 24960519
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recommendations for Clinical CYP2D6 Genotyping Allele Selection: A Joint Consensus Recommendation of the Association for Molecular Pathology, College of American Pathologists, Dutch Pharmacogenetics Working Group of the Royal Dutch Pharmacists Association, and the European Society for Pharmacogenomics and Personalized Therapy.
    Pratt VM; Cavallari LH; Del Tredici AL; Gaedigk A; Hachad H; Ji Y; Kalman LV; Ly RC; Moyer AM; Scott SA; van Schaik RHN; Whirl-Carrillo M; Weck KE
    J Mol Diagn; 2021 Sep; 23(9):1047-1064. PubMed ID: 34118403
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 38.